Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2015 07:00 ET | Source: Lumos Pharma, Inc.

NewLink Genetics Corporation Announces Promising Clinical Data on Indoximod at the Society for Neuro-Oncology Annual Meeting

AMES, Iowa, Nov. 09, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel...
November 09, 2015 07:00 ET | Source: Bio Green Med Solution, Inc.

Mechanistic Rationale for CYC065, Cyclacel’s CDK2/9 Inhibitor, in Targeted Solid Tumors and Hematological Malignancies Presented at AACR-NCI-EORTC International Conference

BERKELEY HEIGHTS, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), today announced the presentation of preclinical...
November 09, 2015 07:00 ET | Source: Pluri Inc.

Pluristem Provides Corporate and Financial Highlights for First Quarter of Its Fiscal Year

HAIFA, Israel, Nov. 09, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, reported financial results for...
November 09, 2015 07:00 ET | Source: Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals Reports 2015 Third Quarter Results

PLYMOUTH MEETING, Pa., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the quarter ended September 30, 2015. Total revenue was...
November 09, 2015 07:00 ET | Source: Vanguard Natural Resources, LLC

Vanguard Natural Resources, LLC Reports Third Quarter 2015 Results

HOUSTON, Nov. 09, 2015 (GLOBE NEWSWIRE) -- Vanguard Natural Resources, LLC (NASDAQ:VNR) (“Vanguard” or “the Company”) today reported financial and operational results for the quarter ended...
November 09, 2015 07:00 ET | Source: Anavex Life Sciences Corp.

Anavex Announces Positive Primary and Secondary Endpoints Were Achieved in a Phase 2a Clinical Trial of ANAVEX 2-73 in Alzheimer’s Disease‎

NEW YORK, Nov. 09, 2015 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL). On Saturday, investigators presented positive safety and cognitive efficacy data...
November 09, 2015 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Announces Podium Presentation of OTREXUP™ Dose Conversion Data at American College of Rheumatology Annual Meeting

EWING, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data derived from its Phase 2 study of the pharmacokinetics of subcutaneous versus oral...
November 09, 2015 07:00 ET | Source: Crestline Hotels & Resorts

Hyatt Place Washington DC/Georgetown/West End Appoints Kevin Varr General Manager and Catherine Rentschler Director of Sales

FAIRFAX, Va., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Crestline Hotels & Resorts, LLC (Crestline) announced today that Kevin Varr has been appointed General Manager for the Hyatt Place Washington...
November 09, 2015 07:00 ET | Source: NXP Semiconductors N.V.

NXP and JAC Capital Complete Bipolar Power JV Following Regulatory Approvals

EINDHOVEN, Netherlands, Nov. 09, 2015 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ:NXPI) and Beijing JianGuang Asset Management Co. Ltd (JAC Capital) today announced that they have...
November 09, 2015 07:00 ET | Source: Sotheby's

Sotheby’s Reports Third Quarter 2015 Financial Results

NEW YORK, Nov. 09, 2015 (GLOBE NEWSWIRE) -- Sotheby’s (NYSE:BID) today reported financial results for the third quarter and nine months ended 30 September 2015. President and Chief Executive...

1 ...208467 208468 208469 ...326072